investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
Expanded Phase II Trial of Carraguard for Prevention of HPV Infection
Mark H. Einstein
0 Collaborator(s)
Funding source
National Institutes of Health (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
Mark H. Einstein
Albert Einstein College of Medicine
Bronx, United States
Related projects
Global Noncommunicable Diseases Intiatives
Development of HPV Vaccine - 2
Cervix uteri
Global Noncommunicable Diseases Intiatives
Sexual and reproductive health, fighting against cervical cancer
Cervix uteri
Jane J Kim
Comparative and Cost-Effectiveness of Preventing HPV-Related Diseases
Cervix uteri
Global Noncommunicable Diseases Intiatives
Cervical Cancer Screening and Preventative Therapy via Reproductive Health Networks (CCS&PT) - 2
Cervix uteri
Global Noncommunicable Diseases Intiatives
Cervical Cancer Screening services
Cervix uteri
Nancy B Kiviat
Chlamydia & Aberrant Dna Methylation in Cervical Cancer
Cervix uteri
Global Noncommunicable Diseases Intiatives
Improved screening and monitoring of pre-cancerous and cancerous cervical lesions in the Cochabamba region of Bolivia - 2
Cervix uteri
Global Noncommunicable Diseases Intiatives
HPV Vaccines: Evidence for Impact - 2
Cervix uteri
Kathryn Anastos
Developing Rwandan Research Capacity in Cervical Cancer and Other Aids Malignancies
Cervix uteri
